C Path
Center for Education & Research on Therapeutics
2002 Arizona CERT

Search WWW
Search azcert.org

scientific advisory board


Raymond L. Woosley, MD, PhD
President and CEO
The Critical Path Institute
Tucson, Arizona 

Board Members

Michael J. Ackerman, MD, PhD
Professor of Medicine, Pediatrics, Pharmacology
Director, Long QT Syndrome Clinic
Mayo Clinic College of Medicine
Rochester, Minnesota

Jeffrey L. Anderson, MD, PhD

Professor of Internal Medicine

Co-Director of Cardiac Research

University of Utah

Associate Chief of Cardiology

LDS Hospital

Salt Lake City, Utah

Charles Antzelevitch, PhD
Masonic Medical Research Laboratory
Utica, New York

Jean T. Barbey, MD
Medifacts International
Rockville, Maryland

Günter E. Breithardt, MD
Westfalische Wilhelms Univ. of Münster
Münster, Germany

Pedro Brugada, MD, PhD
Professor of Cardiology
Cardiovascular Centre
OLV Hospital
Aalst, Belgium

John A. Camm, MD
St. George's Medical School Cardiological Sci.
London, England

Nabil E. El-Sherif, MD
Professor of Medicine and Physiology
State University of New York
Downstate Medical Center
Brooklyn, New York  

Michael R. Franz, MD, PhD
VA Medical Center
Washington, DC  

Christian J. Funck-Brentano, MD, PhD
Department of Pharmacology and Clinical Investigation Center
Saint-Antoine University Hospital
Paris, France


Priv-Doz Dr med Wilhelm Haverkamp
Kardiologie/ Angiologie
Universitätsklinikum Münster
Münster, Germany

Stefan H. Hohnloser, MD
JW Goethe University Cardiology
Department of Medicine
Frankfurt, Germany

Craig January, MD, PhD
Professor of Medicine
University of Wisconsin Hospital
Madison, Wisconsin

Robert M. Kass, MD
Associate Director, Cardiothoracic Surgery
Cedars-Sinai Medical Center
Los Angeles, California

Michael J. Kilborn, MD, PhD
Department of Cardiology
RPA Hospital
Camperdown, Sydney
NSW Australia

Ralph Lazzara, MD
Cardiac Arrhythmia Research Institute
Oklahoma City, Oklahoma

Samuel Levy, MD
Hôpital Nord Chemin des Bourrellys
Marseille, France

Marek Malik, MD, PhD
St. Paul’s Cardiac Electrophysiology
London, United Kingdom

Eduardo Marban, MD, PhD
Johns Hopkins University
Cardiology Ross Building
Baltimore, Maryland

Jay W. Mason, MD
Covance Central Diagnostic
Reno, Nevada

Arthur J. Moss, MD
Professor of Medicine (Cardiology)
University of Rochester Medical Center
Rochester, New York

Silvia Priori, MD, PhD
Molecular Cardiology
Fondazione S. Maugeri, IRCCS
University of Pavia
Pavia, Italy

Eric N. Prystowsky, MD
The Care Group
Indianapolis, Indiana

Dan Roden, MD
Professor, Medicine and Pharmacology
Department of Medicine and Pharmacology
Vanderbilt University
Nashville, Tennessee

Jeremy N. Ruskin, MD
Massachusetts General Hospital Arrhythmia Service
Boston, Massachusetts

Peter J. Schwartz, MD
Professor & Chairman
Department of Cardiology
Policlinico S Matteo IRCCS and University of Pavia
Pavia, Italy

Norman Stockbridge, MD, PhD

Director, Division of Cardiovascular and Renal Products

Center for Drug Evaluation and Research,

U.S. Food and Drug Administration

Silver Spring, Maryland

Robert Temple, MD
Associate Director, Office of Medical Policy
U.S. Food and Drug Administration
Silver Spring, Maryland

Jeffrey A. Towbin, MD
Texas Children’s Hospital
Houston, Texas

Victoria L. Vetter, MD
Children's Hospital of Philadelphia, Cardiology
Philadelphia,  Pennsylvania

G. Michael Vincent, MD
Professor of Medicine, University of Utah
LDS Hospital
Salt Lake City, Utah

Markus Zabel, MD
University of Goettingen
Div. Cardiology
Goettingen, Germany

Douglas P. Zipes, MD
Distinguished Professor of Medicine, Pharmacology, and Toxicology
Director, Krannert Institute of Cardiology and Division of Cardiology
Indiana University School of Medicine
Indianapolis, Indiana



Arizona Center for Education and Research on Therapeutics
The Critical Path Institute

Tucson, Arizona and Rockville, Maryland

Funded in part by Agency for Healthcare Research and Quality grant 1 U18 HS10385-01

Disclaimer and Waiver
The information presented is intended solely for the purpose of providing general information about health related matters. It is not intended for any other purpose, including, but not limited to, medical or pharmaceutical advice and/or treatment, nor is it intended to substitute for the users' relationships with their own health care/pharmaceutical providers. To that extent, by continued use of this program, the user affirms the understanding of the purpose andreleases The Critical Path Institute, The University of Arizona, State of Arizona and Arizona Board of Regents from any claims arising out of his/her use of the website.